Login
← Go Back
Symbiotec Pharmalab
SYMBIOTEC · Pharma > Pharmaceuticals & Drugs Listing date: Sept. 1, 2026
Stock Price vs Company Growth
1d
3.3%
1w
12.2%
1m
13.1%
all
12.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,236 3.3%
934
1,310
Company Overview
Sales
828 Cr
Growth: 0.0%
Profit after Tax
104 Cr
Growth: -13.3%
Mid Cap
7,943 Cr
P/E: 67.7x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 828
Growth 0.0%
EBITDA 26.5%
P/S 9.6x
Dividend 0.0%
P/E 67.7x
Book Value ₹ 1.95
PEG Ratio N/A
ROE 915.5%
P/B N/A
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in the business of manufacturing and selling of Active Pharmaceuticals Ingredients (API) and Intermediates. It caters to both domestic and international markets.
Belongs to (2 Indices)